News

Aalto-born Surgify raises a €1.0M seed investment round

The Surgify Safety burr prevents the nerve and blood vessel injuries that are typically caused by other surgical drills.

A surgeon using the Surgify Safety Burr in a simulated surgery. Photo: Surgify

The technology can be easily used with existing surgical drills, and its usage does not require any additional training for the surgeon or the staff. The patent pending safety mechanism prevents the drill from damaging vital tissues, such as nerves or blood vessels. Besides neurosurgical applications, the innovation can be used in the future also in spine surgery and in the fields of orthopedics and dentistry.

“The technology has raised great interest amongst hospitals and surgeons globally. For example, we recently visited Harvard University’s teaching hospitals in Boston, and the reception was enthusiastic”, tells Visa Sippola, the CEO of Surgify.

The technology has been initially developed in cooperation between Aalto University and Department of Neurosurgery at Helsinki University Hospital. The company aims to bring the Safety Burr technology to the market in 2019. The company thereafter plans to initiate sales in the Nordic Countries, after which it will expand the business to global markets. In addition to the easy adoption process of the technology, the considerable reductions in costs and surgical complications are expected to positively affect the demand for the solution.

“Our core mission is to make bone surgery safer, as we believe that our technology has the potential to save lives in the future. The fact that we also bring clear cost savings to surgery will be of help in carrying out that mission – for example the complications caused by the current surgical drills cost over 4 billion euros each year globally”, Sippola explains.

The investors joining the startup’s second round of financing include a Finnish venture capital firm Butterfly Ventures, as well as Cascara Ventures from Belgium, Merkatura AB (Andreas Bunge) from Sweden and FRIIH GmBH (Dr. Michael Friebe) from Germany. The funding will be used to finalize the neurosurgical burr and to apply for a sales approval in Europe.

Read also: Safer bone surgery thanks to a technique patented at Aalto

Contact:

Visa Sippola
CEO, Surgify Medical
+358 50 353 1232
visa.sippola@surgifymedical.com

  • Updated:
  • Published:
Share
URL copied!

Read more news

Group of people sit around a wooden table discussing, with large maps pinned on the wall behind them.
Research & Art Published:

How trust in digital public services is being built together with migrants in Espoo

Digital public services are not equally accessible to everyone. In Espoo, the Trust-M research project is working to bridge this gap by developing services together with migrants.
Blue e-scooter parked in marked bay on paved path
Press releases, Research & Art Published:

E-scooters are here to stay – first global study maps the state of shared micromobility

Shared e-scooters, city bikes and other small vehicles have evolved from niche experiments into a standard part of urban transport worldwide. Rather than treating micromobility as a passing trend, public authorities should take an active role in shaping its development, researchers argue.
Modern light wood and metal building on a slope, surrounded by tall green trees under blue sky
Research & Art Published:

Aalto University presents circular economy solutions at the New European Bauhaus festival

The European Commission’s New European Bauhaus (NEB) initiative will bring together leading experts and changemakers from across Europe in Brussels this June to shape a more sustainable future.
The new ultrasonic needle allows for two to three times the quantity of tissue to be sampled comparative to current needle biopsy methods. Photo: Kalle Kataila, Aalto University.
Press releases Published:

New ultrasonic needle yields samples 2–3 times larger, potentially reshaping cancer diagnostics

Developed at Aalto University over several years, a new ultrasonic needle for tumour diagnostics has been trialled in collaboration with Helsinki University Hospital (HUS). According to the resulting peer-reviewed study, salivary gland tumours could be diagnosed with far greater precision using the innovative needle.